Gait Initiation and Transition From Double to Single Support in Patients With Unilateral Primary Coxarthrosis (COXAM)

September 17, 2024 updated by: Lille Catholic University

Gait Initiation and Transition From Double to Single Support in Patients With Unilateral Primary Coxarthrosis Who Have Not Undergone Surgery and Before/After Arthroplasty

The study consists to evaluate the impact of prosthetic surgery (PTH and RTH) on kinematic and dynamic parameters (joint torques) of the lower limbs during gait initiation in patients with primary coxarthrosis.

Patients included in the study will undergo a three-dimensional gait analysis. Dynamic gait analysis is multidimensional, measuring kinematic parameters (joint amplitudes: ankles, knees, hips, etc.) and dynamic parameters (assessment of joint torque from ankle, knee, hip to lower limb during gait initiation).

Study Overview

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Marie-Paule LEBITASY
  • Phone Number: +33 3 20 22 52 69
  • Email: urm@ghicl.net

Study Contact Backup

Study Locations

      • Lille, France, 59000
      • Lomme, France, 59462
        • Recruiting
        • Hôpital Saint-Philibert (GHICL)
        • Contact:
        • Principal Investigator:
          • Pierre MARTINOT, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Men or women aged 18 and over
  • With primary coxarthrosis (any stage)
  • Consulting in the orthopedic departments of participating centers in anticipation of hip surgery (PTH/RTH), or for advice only.
  • Written consent signed by the patient
  • Affiliation with a social security scheme

Exclusion Criteria:

  • Disabling orthopaedic conditions:

Symptomatic contralateral hip/knee disease Symptomatic gonarthrosis or homolateral total knee prosthesis History of surgery on the affected hip History of fracture of the lower limb in the past year History of lower limb sprain in the last 3 months Neurological or degenerative disease

  • Pregnant or breast-feeding
  • Adults under guardianship, curatorship or safeguard of justice
  • Cognitive impairment making it impossible to understand the protocol
  • Approach other than Moore posterolateral (for PTH and RTH groups)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Patients with primary coxarthrosis (any stage).
Patients who do not undergo surgery will be called specifically for the study to attend a consultation dedicated to gait assessment.
Experimental: Patients with primary coxarthrosis (any stage) and operated with Total Hip prosthesis (THP).
Patients scheduled for THP (Total Hip Prosthesis) will be seen at the consultation the day before surgery, in the same hospital as the THP, or at an existing dedicated consultation scheduled for all THP patients. During these scheduled visits, they will be received in the gait analysis laboratory for a gait assessment (V1). Patients will be seen again at 6 months post-operatively for a second gait assessment (V2).
Experimental: Patients with primary coxarthrosis (any stage) and operated with RTH (Hip resurfacing).
Patients scheduled for RTH (Hip Resurfacing) will be seen at the consultation the day before surgery, in the same hospital as the RTH, or at an existing dedicated consultation scheduled for all RTH patients. During these scheduled visits, they will be received in the gait analysis laboratory for a gait assessment (V1). Patients will be seen again at 6 months post-operatively for a second gait assessment (V2).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Amplitude degree of lower limbs articulations
Time Frame: 6 months
6 months
Dynamics of limbs joint torques during walking initiation measured in Nm/kg
Time Frame: 6 months
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Step length during gait initiation
Time Frame: 6 months
6 months
Step width during gait initiation
Time Frame: 6 months
6 months
Duration of first step during gait initiation
Time Frame: 6 months
6 months
Duration of anticipatory postural adjustment phase during gait initiation
Time Frame: 6 months
6 months
Duration of execution phase during gait initiation
Time Frame: 6 months
6 months
Measurement of the trajectory during gait initiation
Time Frame: 6 months
6 months
Measurement of the speed during gait initiation
Time Frame: 6 months
6 months
Measurement of the amplitude of retreat of the center of pressure during gait initiation
Time Frame: 6 months
6 months
Severity of coxarthrosis according to the Tönnis classification
Time Frame: 6 Months

The severity of coxarthrosis is assessed on radiographs according to the Tönnis classification:

Grade Radiographic features 0 - No signs of osteoarthritis

  1. - Slight narrowing of joint space

    • Slight lipping at joint margin
    • Slight sclerosis of the femoral head or acetabulum
  2. - Small cysts in the femoral head or acetabulum

    • Increasing narrowing of joint space
    • Moderate loss of sphericity of the femoral head
  3. - Large cysts

    • Severe narrowing or obliteration of joint space
    • Severe deformity of the femoral head
    • Avascular necrosis
6 Months
HHS (Harris Hip Score)
Time Frame: 6 months
The functional score consists of 10 items out of 100 points (best score = 100 points) assessing function, pain and mobility
6 months
PMA (Postel Merle d'Aubigné) score
Time Frame: 6 months
Score on 3 items (pain, mobility and walking) rated on 18 points (18 = excellent results, 0 = worst result)
6 months
Devane score
Time Frame: 6 months
Activity score with 5 possibilities (1 = sedentary work and 5 = power work, competitive sport)
6 months
UCLA (University of California Los Angeles) score
Time Frame: 6 months
Activity score comprising 10 possibilities and assessing the intensity of physical activity (1= inactive or dependent patient, 10 = regular practice of high-impact sports)
6 months
Vellas unipodal weight-bearing test
Time Frame: 6 months
This test consists in asking the patient to balance for as long as possible. A time of more than 30 seconds indicated a very low risk of falls. A time of less than 5 seconds indicates a very high risk of falls.
6 months
Pelvic incidence
Time Frame: 6 months
Pelvic incidence is a constant morphologic parameter that describes the "pelvic size" based on the angular relation between femoral heads and sacral plate for any given person
6 months
Sacral slope angle
Time Frame: 6 months
Spatial orientation of the pelvis in the sagittal plane is assessed by the sacral slope
6 months
Pelvic tilt angle
Time Frame: 6 months
Pelvic tilt is a position-dependent parameter defined as the angle created by a line running from the sacral endplate midpoint to the center of the bifemoral heads and the vertical axis.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Pierre MARTINOT, MD, Hôpital Saint Philibert, GHICL

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 19, 2024

Primary Completion (Estimated)

August 19, 2027

Study Completion (Estimated)

September 1, 2027

Study Registration Dates

First Submitted

February 6, 2024

First Submitted That Met QC Criteria

February 6, 2024

First Posted (Actual)

February 14, 2024

Study Record Updates

Last Update Posted (Actual)

September 19, 2024

Last Update Submitted That Met QC Criteria

September 17, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Primary; Coxarthrosis

Clinical Trials on Patients with primary coxarthrosis (any stage).

Subscribe